The cardiovascular and gastrointestinal adverse effects of cyclooxygenase inhibitors seems to be a major concern that restricts their use in the treatment of urinary bladder dysfunction

Detalles Bibliográficos
Autores principales: Juszczak, Kajetan, Drewa, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2015
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408401/
https://www.ncbi.nlm.nih.gov/pubmed/25914838
http://dx.doi.org/10.5173/ceju.2015.01.e94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408401/
https://www.ncbi.nlm.nih.gov/pubmed/25914838
http://dx.doi.org/10.5173/ceju.2015.01.e94

Ejemplares similares